Literature DB >> 23551104

Class III PI3K Vps34: essential roles in autophagy, endocytosis, and heart and liver function.

Nadia Jaber1, Wei-Xing Zong.   

Abstract

Mammalian phosphatidylinositol (PI) 3-kinases are a family of proteins that share the ability to phosphorylate phosphoinositides at the 3 position of the inositol ring. By doing so, these kinases produce phospholipid molecules that are involved in various cell signaling pathways, such as insulin signaling and endocytosis. The pathways regulated by PI3-kinases are crucial for maintaining cellular homeostasis and thus must be tightly regulated. Irregular PI3-kinase activity is observed in numerous human pathological conditions, such as diabetes, cancer, and inflammation. One family member, Vps34, is of particular interest because it is the only PI3-kinase identified in yeast and it has been evolutionarily conserved through mammals. Vps34 plays an essential role in the cellular process of autophagy, a process linked to human health and disease. Understanding the precise role of mammalian Vps34 will likely be integral to drug development for various diseases.
© 2013 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23551104      PMCID: PMC6686116          DOI: 10.1111/nyas.12026

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  27 in total

1.  Targeting the Autophagy Specific Lipid Kinase VPS34 for Cancer Treatment: An Integrative Repurposing Strategy.

Authors:  Poornimaa Murali; Kanika Verma; Thanyada Rungrotmongkol; Perarasu Thangavelu; Ramanathan Karuppasamy
Journal:  Protein J       Date:  2021-01-05       Impact factor: 2.371

2.  Toll-interacting protein differentially modulates HIF1α and STAT5-mediated genes in fibroblasts.

Authors:  Elizabeth Kowalski; Shuo Geng; Allison Rathes; Ran Lu; Liwu Li
Journal:  J Biol Chem       Date:  2018-06-19       Impact factor: 5.157

Review 3.  Neurodegenerative diseases: model organisms, pathology and autophagy.

Authors:  S N Suresh; Vijaya Verma; Shruthi Sateesh; James P Clement; Ravi Manjithaya
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

Review 4.  Mitophagy and heart failure.

Authors:  Sarah E Shires; Åsa B Gustafsson
Journal:  J Mol Med (Berl)       Date:  2015-01-23       Impact factor: 4.599

Review 5.  Regulatory insights into progression of cancer and Alzheimer's disorder from autophagy perspective.

Authors:  Navneeth Sriram; Mahesh Kumar Sah
Journal:  Mol Biol Rep       Date:  2021-10-19       Impact factor: 2.316

Review 6.  Chronic heart failure: Ca(2+), catabolism, and catastrophic cell death.

Authors:  Geoffrey W Cho; Francisco Altamirano; Joseph A Hill
Journal:  Biochim Biophys Acta       Date:  2016-01-13

7.  Class III PI3K Vps34 Controls Thyroid Hormone Production by Regulating Thyroglobulin Iodination, Lysosomal Proteolysis, and Tissue Homeostasis.

Authors:  Giuseppina Grieco; Tongsong Wang; Ophélie Delcorte; Catherine Spourquet; Virginie Janssens; Aurélie Strickaert; Héloïse P Gaide Chevronnay; Xiao-Hui Liao; Benoît Bilanges; Samuel Refetoff; Bart Vanhaesebroeck; Carine Maenhaut; Pierre J Courtoy; Christophe E Pierreux
Journal:  Thyroid       Date:  2019-12-02       Impact factor: 6.568

8.  ATG14 and RB1CC1 play essential roles in maintaining muscle homeostasis.

Authors:  Dongfang Li; Peter Vogel; Xiujie Li-Harms; Bo Wang; Mondira Kundu
Journal:  Autophagy       Date:  2021-04-14       Impact factor: 16.016

9.  The G-Protein Rab5A Activates VPS34 Complex II, a Class III PI3K, by a Dual Regulatory Mechanism.

Authors:  Thomas C Buckles; Yohei Ohashi; Shirley Tremel; Stephen H McLaughlin; Els Pardon; Jan Steyaert; Moshe T Gordon; Roger L Williams; Joseph J Falke
Journal:  Biophys J       Date:  2020-10-31       Impact factor: 4.033

10.  PDPK1 regulates autophagosome biogenesis by binding to PIK3C3.

Authors:  Boli Hu; Yina Zhang; Tingjuan Deng; Jinyan Gu; Juan Liu; Hui Yang; Yuting Xu; Yan Yan; Fan Yang; Heng Zhang; Yulan Jin; Jiyong Zhou
Journal:  Autophagy       Date:  2020-09-10       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.